Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pseudomonas Gastrointestinal Tract Infection”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Not applicableUnknownNCT03910920
What this trial is testing

Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center.

Who this might be right for
Cystic FibrosisPseudomonas AeruginosaCross Infection
Queen Fabiola Children's University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01035853
What this trial is testing

Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
University of Jena 10
Testing effectiveness (Phase 2)Study completedNCT04596319
What this trial is testing

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

Who this might be right for
Cystic FibrosisPseudomonas AeruginosaPseudomonas+2 more
Armata Pharmaceuticals, Inc. 29
Post-approval studies (Phase 4)Ended earlyNCT02248922
What this trial is testing

Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa

Who this might be right for
Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis
Novartis Pharmaceuticals 17
Large-scale testing (Phase 3)Study completedNCT00712166
What this trial is testing

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa

Who this might be right for
Cystic FibrosisLung InfectionPseudomonas Aeruginosa
Gilead Sciences 160
Not applicableStudy completedNCT01616862
What this trial is testing

The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis

Who this might be right for
Pseudomonas AeruginosaCystic Fibrosis
Zafer Soultan 53
Large-scale testing (Phase 3)Study completedNCT00128492
What this trial is testing

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

Who this might be right for
Cystic Fibrosis
Gilead Sciences 274
Post-approval studies (Phase 4)Study completedNCT00411736
What this trial is testing

Scandinavian Cystic Fibrosis Azithromycin Study

Who this might be right for
Cystic Fibrosis
Rigshospitalet, Denmark 45
Large-scale testing (Phase 3)Study completedNCT01641822
What this trial is testing

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Who this might be right for
Cystic Fibrosis
Gilead Sciences 107
Testing effectiveness (Phase 2)Study completedNCT05010577
What this trial is testing

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis
BiomX, Inc. 43
Large-scale testing (Phase 3)WithdrawnNCT01315691
What this trial is testing

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Insmed Incorporated
Large-scale testing (Phase 3)Study completedNCT01315678
What this trial is testing

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Who this might be right for
Pseudomonas Aeruginosa Infection
Insmed Incorporated 302
Testing effectiveness (Phase 2)Study completedNCT01695343
What this trial is testing

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Who this might be right for
Cystic Fibrosis
Humanigen, Inc. 182
Testing effectiveness (Phase 2)Study completedNCT01055847
What this trial is testing

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Who this might be right for
Cystic FibrosisCFLung Infection+1 more
Gilead Sciences 105
Not applicableUnknownNCT05675592
What this trial is testing

Trikafta/Kaftrio and Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Ospedale San Raffaele 20
Post-approval studies (Phase 4)Study completedNCT01844778
What this trial is testing

Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT00043225
What this trial is testing

The Role of Bacteria and Genetic Variations in Cystic Fibrosis

Who this might be right for
Psuedomas InfectionCystic Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 76
Testing effectiveness (Phase 2)Looking for participantsNCT06016088
What this trial is testing

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Who this might be right for
Cystic Fibrosis LungRespiratory Infections, Recurrent, ChronicPseudomonas Aeruginosa
Respirion Pharmaceuticals Pty Ltd 72
Not applicableStudy completedNCT01818206
What this trial is testing

Bacteriophage Effects on Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
University Hospital, Montpellier 59
Large-scale testing (Phase 3)Study completedNCT01069705
What this trial is testing

Second Open Label Extension to Bridging Study CTBM100C2303

Who this might be right for
Pulmonary InfectionsPseudomonas Aeruginosa
Novartis Pharmaceuticals 49
Load More Results